Javascript must be enabled to continue!
Molecular Circuits of Immune Sensing and Response to Oncolytic Virotherapy
View through CrossRef
Oncolytic virotherapy is a promising immunotherapy approach for cancer treatment, utilizing viruses to preferentially infect and eliminate cancer cells while stimulating immune responses. In this review we synthesize current literature on the molecular circuits of immune sensing and response to oncolytic virotherapy; focusing on viral DNA or RNA sensing by infected cells, cytokine and danger-associated signal sensing by neighboring cells, and subsequent downstream activation of immune pathways. The sequential sense-and-response mechanisms involve the triggering of molecular sensors by viruses or infected cells to activate transcription factors and related genes for a breadth of immune responses. We describe how molecular signals induced in the tumor upon virotherapy can trigger diverse immune signaling pathways, activating both antigen-presenting cell-based innate and T cell-based adaptive immune responses. Insights into these complex mechanisms provide valuable knowledge for enhancing oncolytic virotherapy strategies.
Title: Molecular Circuits of Immune Sensing and Response to Oncolytic Virotherapy
Description:
Oncolytic virotherapy is a promising immunotherapy approach for cancer treatment, utilizing viruses to preferentially infect and eliminate cancer cells while stimulating immune responses.
In this review we synthesize current literature on the molecular circuits of immune sensing and response to oncolytic virotherapy; focusing on viral DNA or RNA sensing by infected cells, cytokine and danger-associated signal sensing by neighboring cells, and subsequent downstream activation of immune pathways.
The sequential sense-and-response mechanisms involve the triggering of molecular sensors by viruses or infected cells to activate transcription factors and related genes for a breadth of immune responses.
We describe how molecular signals induced in the tumor upon virotherapy can trigger diverse immune signaling pathways, activating both antigen-presenting cell-based innate and T cell-based adaptive immune responses.
Insights into these complex mechanisms provide valuable knowledge for enhancing oncolytic virotherapy strategies.
Related Results
EPD Electronic Pathogen Detection v1
EPD Electronic Pathogen Detection v1
Electronic pathogen detection (EPD) is a non - invasive, rapid, affordable, point- of- care test, for Covid 19 resulting from infection with SARS-CoV-2 virus. EPD scanning techno...
CHALLENGES AND FUTURE PROSPECTS OF ONCOLYTIC VIROTHERAPY: A SYSTEMATIC REVIEW
CHALLENGES AND FUTURE PROSPECTS OF ONCOLYTIC VIROTHERAPY: A SYSTEMATIC REVIEW
Background: Oncolytic virotherapy has emerged as a novel and promising approach in cancer treatment, leveraging viruses that selectively infect and destroy malignant cells while sp...
Vesicular Stomatitis Virus-Based Oncolytic Virotherapy: Recent Progress and Emerging Trends
Vesicular Stomatitis Virus-Based Oncolytic Virotherapy: Recent Progress and Emerging Trends
Oncolytic virotherapy has emerged as a promising and innovative approach to cancer treatment, leveraging viruses that selectively replicate in tumor cells and cause their destructi...
Dynamic analysis and optimal control of cancer oncolytic virotherapy model with chemotherapy and immune response
Dynamic analysis and optimal control of cancer oncolytic virotherapy model with chemotherapy and immune response
Abstract
Oncolytic virotherapy is another therapeutic treatment for cancer and has been greatly interested recently by many researchers. In this study, a mathematical model...
Tumor Restrictions to Oncolytic Virus
Tumor Restrictions to Oncolytic Virus
Oncolytic virotherapy has advanced since the days of its conception but therapeutic efficacy in the clinics does not seem to reach the same level as in animal models. One reason is...
Safety and Efficacy of Atezolizumab in Ovarian Cancer
Safety and Efficacy of Atezolizumab in Ovarian Cancer
Abstract
Introduction
Although the efficacy of PD-L1 blockade has been evaluated in analyses that combine pharmacologically distinct antibodies, the specific efficacy and safety of...
Abstract 4934: Immunostimulatory and oncolytic properties of rotavirus can overcome resistance to immune checkpoint blockade therapy
Abstract 4934: Immunostimulatory and oncolytic properties of rotavirus can overcome resistance to immune checkpoint blockade therapy
Abstract
Immune checkpoint targeted therapies against PD-1, PD-L1 and CTLA-4 are currently revolutionizing cancer care. However, only a minority of patients generate...
Analysis and Control of Oncolytic Virotherapy Dynamic Models
Analysis and Control of Oncolytic Virotherapy Dynamic Models
Oncolytic virotherapy is a cancer treatment that uses viruses to selectively infect and destroy cancer cells while leaving healthy cells unharmed. These viruses, known as oncolytic...

